(Q33538422)

27 July 2017

1 reference

title

Prognostic implications of expression of the cell cycle inhibitor protein p27Kip1. (English)

1 reference

27 July 2017

Cariou S

1

1 reference

27 July 2017

Catzavelos C

series ordinal

2

1 reference

27 July 2017

Slingerland JM

series ordinal

3

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

Breast Cancer Research and Treatment

27 July 2017

1 reference

27 July 2017

52

1 reference

27 July 2017

29-41

1 reference

27 July 2017

1-3

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1006154900130

27 July 2017

0 references

cites work

Activation of the various cyclin/cdc2 protein kinases

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Principles of CDK regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

G1 phase progression: cycling on cue

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Inhibitors of mammalian G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Creative blocks: cell-cycle checkpoints and feedback controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

WAF1, a potential mediator of p53 tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Effects of ionizing radiation on cell cycle progression. A review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Redistribution of the CDK inhibitor p27 between different cyclin.CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Inhibition of cyclin-dependent kinases by p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Transforming growth factor beta stabilizes p15INK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Cyclin D1 as a cellular proto-oncogene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

A cell cycle-regulated inhibitor of cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Oligodendrocyte precursor differentiation is perturbed in the absence of the cyclin-dependent kinase inhibitor p27Kip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Translational control of p27Kip1 accumulation during the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Ras activity late in G1 phase required for p27kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Induction of p27Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Cyclin E-CDK2 is a regulator of p27Kip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Anchorage-dependent cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Dependence of cyclin E-CDK2 kinase activity on cell anchorage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Overexpression of the integrin-linked kinase promotes anchorage-independent cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Protein expression of the cell-cycle inhibitor p27Kip1 in malignant melanoma: inverse correlation with disease-free survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Third annual William L. McGuire Memorial Lecture. "Studies on the estrogen receptor in breast cancer"--20 years as a target for the treatment and prevention of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

G1 control in mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

7 January 2021

Rates of p16 (MTS1) mutations in primary tumors with 9p loss

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

7 January 2021

Frequency of homozygous deletion at p16/CDKN2 in primary human tumours

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

7 January 2021

Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

7 January 2021

Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

7 January 2021

Mutational analysis of the human cyclin-dependent kinase inhibitor p27kip1 in primary breast carcinomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

7 January 2021

Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

7 January 2021

p27 expression and gastric carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

7 January 2021

Prediction of recurrence for advanced breast cancer. Traditional and contemporary pathologic and molecular markers.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

7 January 2021

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006154900130

7 January 2021

Identifiers

DOI

10.1023/A:1006154900130

1 reference

Dimensions Publication ID

27 July 2017

0 references

1 reference